Boston Scientific Wins 14-year NIR Stent Patent Case Against J&J

Medical devices maker Boston Scientific Corp. (BSX: News ) announced Wednesday that the U.S. Court of Appeals for the Federal Circuit found that its NIR Stent did not infringe Johnson & Johnson's (JNJ: News ) Fischell patent held by its subsidiary Cordis Corp. "We are pleased with the decision and will continue to manage our litigation risks as part of our continuing effort to reduce our exposure," said Tim Pratt, Executive Vice...